CureSearch is excited to announce that Merck has joined the 2024 CureSearch Pediatric Early Development Symposium as a sponsor. This virtual event on October 9th and 10th will bring together key experts and stakeholders in the field of pediatric cancer drug development to address timely challenges and emerging opportunities in the field.
With over 130 years of experience, Merck has been at the forefront of creating vital medicines and vaccines that enhance and save lives globally. Their oncology research is pioneering, focusing on breakthrough treatments across more than 30 tumor types, making it one of the most extensive development programs in the industry.
Merck’s dedication to the cancer community shines through in their collaborative approach, partnering with advocacy groups, healthcare providers, governments, and industry peers. Their mission is to create programs that support patients and caregivers throughout their cancer journeys and provide grants to organizations committed to helping those impacted by the disease.
To learn more about Merck’s impactful work, visit: Merck. For a closer look at their oncology research, explore: Merck Oncology.
Thank you, Merck, for your generous support of CureSearch’s Pediatric Early Development Symposium. Together, we are dedicated to innovating and improving cancer treatment for children.To register for 2024 PEDS, please visit: curesearch.org/peds2024.
